Sertoli cell proliferation occurs in two major waves after birth, one neonatally and another prepubertally, each contributing to final testicular size and sperm production. However, little is known about the regulation of either wave. We have previously shown that letrozole, an inhibitor of estrogen synthesis, increases Sertoli cell number and testicular size at sexual maturity in boars. These studies were conducted to determine whether letrozole affects the first or second proliferative wave. Boars were treated with letrozole during the first wave (treatment at 1, 3, and 5 weeks), less frequently (1 week of age only, or 1 and 5 weeks), on postnatal day 1, or during the second wave (weeks 11-16). Sertoli cells were enumerated in testes and estrogen concentrations were evaluated in serum and testes. Compared with vehicle controls, letrozole reduced estrogen in boars treated at weeks 1 and 5 or 1, 3, and 5, on postnatal day 1, or prepubertally. However, Sertoli cell numbers were increased only in boars treated at 1, 3, and 5 weeks of age. Neither perinatal (1 day old) nor prepubertal letrozole treatment affected Sertoli cell numbers. Hence, Sertoli cell proliferation was sensitive to letrozole only if letrozole was administered throughout the first wave, even though estrogen synthesis was effectively inhibited at all ages. These data indicate that the neonatal but not the prepubertal window of Sertoli cell proliferation is sensitive to an inhibitor of estrogen synthesis; this suggests that these two waves are differently regulated.
Introduction
Sperm production capacity and testicular size in mammals are positively correlated with size of the Sertoli cell population (Berndtson et al. 1987) . Hence, increased understanding of Sertoli cell proliferation and development is important to those interested in animal agriculture. As abnormalities in Sertoli cell development and proliferation contribute to testicular dysgenesis syndrome in humans (Wohlfahrt-Veje et al. 2009 ), increased understanding is also important to the biomedical community. Previous studies in our laboratory have demonstrated that the administration of letrozole, an inhibitor of estrogen synthesis, beginning in the neonatal period promotes proliferation of Sertoli cells in boars. This results in an w25% increase in Sertoli cell number, testicular weight, and sperm production (At-Taras et al. 2006a , Berger et al. 2008 . Mechanisms regulating this increase are not yet well understood, although existing data suggest local rather than systemic mediation (At-Taras et al. 2006b) .
Compensatory testicular growth is a well-recognized response to hemicastration. In boars, the degree to which growth of the remaining testis is stimulated depends on the age of the boar (Putra & Blackshaw 1982 , 1985 , Lunstra et al. 2003 , Ford et al. 2010 . Although the earlier the age of hemicastration, the greater is the weight of the remaining testis at maturity; the remaining testis never exceeds the weight or sperm production equivalent to two mature testes. Testicular size can be increased in some rodents by transient neonatal hypothyroidism, but induced hypothyroidism has not had an effect in pigs suggesting species differences in regulatory mechanisms (Hess et al. 1993 , Joyce et al. 1993 , Tarn et al. 1998 , Klobucar et al. 2003 , Jansen et al. 2007 . In contrast, letrozole treatment in developing boars promotes testicular growth and sperm production that significantly exceeds that of untreated boars. As such, letrozole treatment offers the potential to enhance the reproductive capacity of mature boars, and may provide insights into the regulation of Sertoli cell proliferation in mammals using this high endogenous estrogen male. However, the developmental interval(s) of response (age dependence) is undefined.
During normal development, Sertoli cells are believed to complete proliferation prepubertally and undergo differentiation/maturation before lumen formation within seminiferous tubules. Postnatal proliferation of Sertoli cells occurs in two waves during the prepubertal interval (Franca et al. 2000 , Sharpe et al. 2003 . The first wave of Sertoli cell proliferation in Piau pigs is reported to occur before 1 month and the second wave just before puberty, between 3 and 4 months of age. Whether these two waves of proliferation are regulated by similar physiological cues is unknown. Similarly, while continuous inhibition of aromatase activity led to an w25% increase in number of Sertoli cells and testicular weight in boars after sexual maturity (At-Taras et al. 2006a) , whether this had differential effects on the first and second wave is unknown. In our previous studies (At-Taras et al. 2006a , Berger et al. 2008 , the effects of letrozole on Sertoli cell proliferation in the first wave could not be distinguished from the effects on the second, prepubertal wave of proliferation. Understanding the time intervals when Sertoli cells are sensitive to this treatment and when they are insensitive is critical for further studies investigating mechanism(s) by which aromatase inhibition influences Sertoli cell proliferation, postpubertal testicular size, and sperm production. The current studies were designed to evaluate the effects of letrozole administered during each of the two postnatal waves of Sertoli cell proliferation, thereby providing insight into the physiological regulation of this process.
Results
Boars treated with letrozole at 1, 3, and 5 weeks of age had significantly more Sertoli cells at 6.5 weeks of age than their littermates receiving the canola oil vehicle (Fig. 1) or littermates treated only at 1 week of age. Sertoli cell density was similarly increased (Table 1) . Testicular tissue levels of estradiol (E 2 ) were dramatically reduced by treatment at 1, 3, and 5 weeks and by treatment at 1 and 5 weeks (Fig. 2) . Levels of LH or FSH in the circulation did not vary among treatments (Table 1) .
Boars treated with letrozole at 1 day of age exhibited markedly reduced circulating E 2 at 9 days of age at time of tissue retrieval (13.7 pg/ml compared with 38.8 for vehicle control littermates). Sertoli cell numbers per testis were similar between the vehicle controls and the letrozole-treated littermates at 9 days of age (0.21 vs 0.15 billion per testis, respectively, S.E.M.Z0.04). Proliferation rate for Sertoli cells at 9 days of age assessed by percentage of phosphorylated histone 3-labeled cells (Fig. 3) was also similar between vehicle controls and letrozole-treated littermates (7.8 and 8.0%, S.E.M.Z0.3). No effects of treatment on circulating testosterone, LH, or FSH were observed (Table 2) .
In contrast to boars treated from 1 to 5 weeks of age, the number of Sertoli cells per testis was similar in boars treated with letrozole from 11 to 15 weeks and vehicle control littermates at 16 weeks of age (Fig. 4) and remained similar at 20 and 40 weeks of age. Despite the insensitivity of Sertoli cell numbers to letrozole treatment from 11 to 16 weeks of age, testicular aromatase activity at 16 and 20 weeks of age was dramatically reduced by the treatment (Fig. 5) . Although aromatase activity was arithmetically lower in 40-week boars treated with letrozole from 11 to 16 weeks of age compared with vehicle control littermates, this apparent reduction was not significant. The effect on aromatase was reflected in estrogen concentration. Circulating E 2 levels were markedly reduced within 1 week of treatment (24 vs 11 pg/ml, S.E.M.Z4, P!0.01), demonstrating an immediate effect on aromatase activity, and testicular E 2 and, estrogen conjugates were reduced at 16 and 20 weeks of age (Figs 6 and 7). Testicular tissue levels of testosterone Values represent least squares means for four boars except the 1-, 3-, and 5-week value, which is the mean of three boars from three different litters. (Corbin et al. 2009 ); 400 ml sample volumes extracted with ether to lower assay detection limit to 5 pg/ml but values in some samples were lower. Values previously reported (Corbin et al. 2009 ). c Testes weight for boars treated with letrozole at 1, 3, and 5 weeks of age differed from littermates treated with vehicle, P!0.05. (Table 3 ) and circulating LH and FSH concentrations were not altered by treatment (1.2 vs 1.6 ng LH/ml, S.E.M.Z0.3, and 7.1 vs 7.6 ng FSH/ml, S.E.M.Z0.5 in 12-to 14-week vehicle control vs letrozole-treated animals respectively). Neither testicular sperm production (detergent-resistant spermatid numbers) nor testis weight was different between treated and control boars at any age in this experiment (Table 3) .
Discussion
The results of the data reported here not only define the period of Sertoli cell proliferation that is responsive to inhibition of aromatase but also provide insight into the regulation of the process and its age dependence. The letrozole-induced increase in Sertoli cell numbers at 6.5 weeks in boars treated at 1, 3, and 5 weeks mirrors the results of a previous study in which boars were treated with letrozole continuously through 8 months of age (At-Taras et al. 2006a) , and when treatment was restricted to the first 3 months of life (Berger et al. 2008) . Just as importantly, the absence of effect in boars treated only at 1 day of age, 1 week of age only, 1 and 5 weeks of age, or between 11 and 16 weeks of age clearly defines the period during which Sertoli cell proliferation in the boar is sensitive to an aromatase inhibitor. The sensitive interval is neither perinatal nor peripubertal, and sensitivity requires letrozole exposure to be present at 3 weeks of age. This suggests that the letrozole effect is either mediated over a prolonged interval or after 3 weeks postnatally. The lack of an effect of letrozole treatment on 1-day-old boars is of interest because rapid rates of Sertoli proliferation have been reported for this early postnatal interval (McCoard et al. 2001) . Our data suggest that proliferation during the immediate postnatal interval is not sensitive to aromatase inhibition but becomes responsive after the first 3 weeks of life. This is a developmental interval during which endogenous circulating estrogen concentrations are declining naturally (Ford 1983 , Schwarzenberger et al. 1993 ) and may define the important period of Sertoli cell proliferation in a physiological context also. The reduced estrogen concentrations in tissues and serum of letrozole-treated boars confirmed that the lack of response during this interval was not due to a failure of the drug to inhibit estrogen synthesis, suggesting that there must be a change in the responsiveness that affects Sertoli cell proliferation itself. Whether this is due to neonatal changes in steroid receptor expression or changes in other components of the response pathway remain to be determined; both ESR1 and ESR2 are present in Sertoli cells and peritubular myoid cells (Ramesh et al. 2007) . Despite the inhibition of estrogen, testosterone concentrations were not significantly altered. Testosterone is the immediate substrate for E 2 synthesis by P450arom, and inhibition of aromatase activity might be thought to result in an accumulation of substrate. However intuitive, previous studies on enzyme activities in testes of neonatal boars, specifically aromatase and 17,20-lyase, the last and limiting step in androgen synthesis, indicate that a 100-fold difference exists between the two in favor of 17,20-lyase (Moran et al. 2002) . Such a large differential predicts that inhibition of P450arom would impact only a small fraction of the androgen substrate that would otherwise undergo aromatization; hence, little change in testosterone would be expected. The current and previous observations in boars treated with letrozole are consistent with this prediction. Interestingly, the second wave of Sertoli cell proliferation was not sensitive to aromatase inhibition. There were no indications of increased Sertoli cell numbers immediately after aromatase inhibition from weeks 11-15 near the end of the second wave nor did any develop at 20 or 40 weeks of age postpubertally. This was despite inhibition of testicular aromatase and concomitantly reduced estrogens in effect through 20 weeks of age. Hence, future experiments designed to evaluate and manipulate Sertoli cell proliferation by reducing endogenous estrogens should focus on the first wave, including the latter part of the first wave of proliferation. This idea is consistent with the hypothesis that reducing endogenous estrogens prolongs the first wave of Sertoli cell proliferation (Kao D & Berger T, unpublished observations). A similar explanation of prolonged interval for proliferation was suggested for the difference in Sertoli cell numbers between slower maturing boars with large testes and more rapidly maturing boars with smaller testes (Lunstra et al. 2003) . In addition, as current and previous evidence support local testicular mediation rather than systemic mediation of the stimulus on Sertoli cell proliferation, these observations suggest that regulation of proliferation differs between the first and second waves.
Another experimental strategy to increase testis size is hemicastration. The circulating levels of FSH are increased for several weeks following hemicastration and are believed to mediate the Sertoli cell proliferation that follows (Kosco et al. 1987) . In contrast, we did not detect an increase in FSH at 9 days of age, at 6.5 weeks of age, or following treatment from 11 to 16 weeks of age. In fact, these and previous data from our laboratory have found no evidence of an increase in FSH as part of the short-term or the long-term response to letrozole (At-Taras et al. 2006b ). This suggests that estrogen does not play a significant role in negative feedback of the hypothalamic-pituitary axis in boars (At-Taras et al. 2006a) and that the testicular response to letrozole does not include an increase in FSH drive. Thus, the increase in testis size and sperm production at sexual maturity in response to hemicastration likely involves different mechanisms than those driving the response to letrozole.
The results of the current studies confirm that the first wave of Sertoli cell proliferation is sensitive to endogenous estrogens. As we previously observed, reduction of endogenous estrogens increased Sertoli cell proliferation. Furthermore, these results suggest that letrozole treatment is most effective after 3 weeks of age. These experiments were the first to evaluate sensitivity of Sertoli cell proliferation during the interval corresponding to the second wave independent of the first wave and demonstrated that the second wave of Sertoli cell proliferation was not sensitive to endogenous estrogens in pigs.
Materials and Methods

Animals and treatment
Sensitivity of the first wave of Sertoli cell proliferation to inhibition of aromatase independent of the second wave was evaluated in two experiments. Letrozole (CGS 20 267; 4-40-(1H-1,2,4-triazol-1-yl-methylene)-bis-benzonitrile; CibaGeigy, Basel, Switzerland), a nonsteroidal aromatase inhibitor, was used in these studies as in our previous studies. Response to letrozole treatment during weeks 1-5 of age was investigated in the first experiment. Although endogenous estrogens are suppressed for at least 4 weeks following treatment in a mature boar (Berger et al. 2008) , we hypothesized that effective inhibition might be shorter in growing animals. Inhibition for 2 weeks following a single oral dose of letrozole treatment was verified (preliminary data not shown); hence, treatment every other week was the most frequent treatment used for the piglets treated between 1 and 5 weeks of age. A boar was randomly assigned to receive 0.1 mg letrozole/kg body weight orally at 1, 3, and 5 weeks of age, a second littermate to receive the same dose at 1 and 5 weeks of age, the third littermate to receive that dose only at 1 week of age, and the fourth to receive the canola oil vehicle. Additional littermates were randomly assigned to one of the preceding treatments. Animals were weighed before treatment and 15 boars from three litters completed the study. At 6.5 weeks of age, animals were weighed, blood samples were obtained, animals were killed (86 mg pentobarbital sodium/kg body weight, Vortech Pharmaceuticals, Dearborn, MI, USA), and tissues were retrieved following killing. Testes were weighed, one sample was fixed in 4% paraformaldehyde for determination of Sertoli cell density, and a second sample was frozen on dry ice for subsequent determination of testicular steroid levels. Hypothalamic and testicular aromatase activities were previously reported for these boars (Corbin et al. 2009 ). The second experiment further investigated the initial phase of the first wave of Sertoli cell proliferation. One member of each littermate pair of boars was randomly assigned to receive letrozole at 1 day of age and the other littermate received the oil vehicle. Blood samples were obtained and testicular tissue was retrieved at 9 days of age following killing. Testes were weighed and a sample was fixed in 4% paraformaldehyde for determination of Sertoli cell density and Sertoli cell proliferation.
The sensitivity of the second wave of Sertoli cell proliferation to reduced aromatase activity was evaluated in a third experiment. Littermate sextets of boars were randomly assigned to treatment with the aromatase inhibitor letrozole (three littermates) or the canola oil vehicle control (three littermates). Weekly treatment began at 11 weeks of age and continued through 16 weeks of age. Boars were weighed and food withdrawn for w3 h before dosing. For treatment, boars were introduced individually to pens and a small amount of feed (100 g) was top-dressed with canola oil vehicle or letrozole suspended in canola oil vehicle to provide 0.1 mg letrozole/kg body weight (or the equivalent amount of oil). Blood samples were obtained at 12 and 14 weeks of age as well as following killing by electrocution. Tissues were recovered from one treated and one vehicle control boar from each litter at 16 weeks of age (treated weekly from 11 to 15 weeks of age), 20 weeks of age, and 40 weeks of age. Testes were weighed, two pieces of testis from each boar were processed as described for the 6.5 week boars, and a third sample of 1 g was stored at K17 8C until homogenization for determination of detergentresistant spermatids. This experiment was replicated using six littermate boars from each of five different litters.
Boars in experiments 1 and 3 were of Sygen ancestry and derived from breeding stock and semen donated by PIC USA (Franklin, KY, USA). The boars used in experiment 2 were crossbred with Yorkshire sires. All animals were used in accordance with Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching and approved by the Institutional Animal Care and Use Advisory Committee.
Hormone assays
Blood was collected by jugular venipuncture in 10 ml vacutainer tubes, cooled to 4 8C, centrifuged at w1300 g for 10 min, aliquoted, and plasma was stored at K20 8C until assayed. Testis tissue (stored at K80 8C) was homogenized in 10 volumes of homogenization buffer (0.1 M potassium phosphate buffer (pH 7.4) containing 20% glycerol, 5 mM b-mercaptoethanol, and 0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) (Sigma; Corbin et al. 1999 , Moran et al. 2002 , sonicated for 3 s, and centrifuged at 15 000 g for 10 min. Tissue supernate was analyzed for protein concentration using a Coomassie dye (Coomassie Protein Assay Kit, Thermo Fisher Scientific, Inc., Rockford, IL, USA) and stored at K20 8C until assayed for E 2 , estrogen conjugates, and testosterone. Plasma concentrations of E 2 , estrogen conjugates, testosterone, LH, and FSH and testicular tissue The LH RIA used a mouse monoclonal anti-bovine LH (518B7, Roser) and porcine LH (EX275A, Papkoff) standards and the FSH RIA used rabbit anti-porcine FSH (R285; courtesy of H Papkoff, University of California, Davis, CA, USA) and iodinated porcine FSH (EX274B, Papkoff) standards. The sensitivity and intra-and interassay coefficients of variation (CV) for E 2 were 10 pg/ml, 11.2 and 9.9%. Cross-reactivity for this antibody with estrone is 3% (Korenman et al. 1974) . The sensitivity and intra-and interassay CV for testosterone were 0.1 ng/ml, 6.8 and 11.4%. Cross-reactivities of 69, 14, 20, and 8.6% were previously reported for dihydrotestosterone, 3a-and 3b-androstanediol, and nortestosterone respectively (Gay & Kerlan 1978 , At-Taras et al. 2006b ). The sensitivity and intraand interassay CV for estrogen conjugates were 0.2 ng/ml, 8.3 and 10.9%. The sensitivity and intra-assay CV for FSH and LH were 1 and 0.25 ng/ml and 9.1 and 7.2% respectively.
Sperm and Sertoli cell counts, cell proliferation, and aromatase activity
One gram samples of testis were homogenized with 20 ml sterile, aqueous 0.9% NaCl/0.05% Triton X-100 at room temperature for 3 min using a Potter Elvehjem tissue grinder (Amann & Lambiase 1969 , McCarthy et al. 2006 . The homogenizer was rinsed, the fluid added to the homogenate, and the total volume measured. Average cell density was determined from a minimum of three counts from hemocytometer grids that were within 10% of each other and total numbers determined by multiplying cell density by total volume. Sertoli cell numbers per testis were determined as described previously (At-Taras et al. 2006a) using GATA4 labeling of 25 mm sections from paraffin blocks and the CASTGrid system. Proliferation rate of Sertoli cells was assessed using immunohistochemical detection of phosphorylated histone 3 as a marker for proliferating cells in 5 mm paraffin sections (Brenner et al. 2003) . The primary antibody (SC-8656; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was used at 1:400 dilution in Tris-buffered saline and bound antibody visualized with a goat antibody to rabbit IgG followed by signal amplification and use of 3-amino-9-ethylcarbazole as a chromagen (Vectastain Elite ABC kit, PK6101 and SK4200; Vector Laboratories, Burlingame, CA, USA). Proliferation rate was determined after evaluating 500 Sertoli cells and expressed as a percentage. Aromatase activities were conducted as described and reported previously , Corbin et al. 2003 .
Statistical analysis
Data were subjected to ANOVA using SAS statistical programs (Proc MIXED; SAS Institute, Cary, NC, USA). Litter was considered a random factor and treatment as a fixed factor. When necessary for normality constraints (LH values at 12 and 14 weeks, tissue E 2 values at 16 and 20 weeks, and tissue estrogen conjugate values at 20 weeks), data were subjected to log transformation and reported P values are from the transformed data. Differences between means were evaluated using linear contrasts. The P values !0.05 were considered significant.
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